PI3King the right partner: unique interactions and signaling by p110β

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Phosphoinositide 3-kinases (PI3Ks) are crucial for cellular signaling pathways controlling growth, proliferation, migration, and metabolism.
• Class I PI3Ks are activated by Receptor Tyrosine Kinases (RTKs) or G Protein-Coupled Receptors (GPCRs), and their dysregulation is implicated in various diseases.
• The p110β isoform of Class I PI3K uniquely interacts with both RTKs and GPCRs, and additionally binds to Rho-GTPases and Rab5.

Purpose of the Study:

• To review recent advancements in understanding the p110β isoform of Phosphoinositide 3-kinase.
• To focus on the interacting partners of p110β, including Rho-GTPases and Rab5.
• To elucidate the binding mechanisms, regulation, and functional significance of these interactions in cellular signaling.

Main Methods:

• Literature review of recent studies on p110β.
• Analysis of research characterizing p110β interacting partners.
• Synthesis of findings related to binding mechanisms and regulatory roles.

Main Results:

• Recent studies have identified and characterized key interacting partners of p110β, such as Rho-GTPases and Rab5.
• The molecular mechanisms governing the binding and regulation of p110β by these partners have been elucidated.
• These interactions are critical for p110β's diverse roles in cellular physiology and disease pathogenesis.

Conclusions:

• The unique interaction profile of p110β with RTKs, GPCRs, Rho-GTPases, and Rab5 highlights its central role in integrating multiple signaling pathways.
• Understanding these interactions provides critical insights into p110β's function in normal cellular processes and its contribution to disease.
• Further research into p110β signaling pathways holds potential for therapeutic interventions in diseases associated with PI3K dysregulation.